Diabetes Care, Vol 16, Issue 11 1446-1452, Copyright © 1993 by American Diabetes Association

ARTICLES

Symptoms of sensory neuropathy in adults with NIDDM in the U.S. population

M Harris, R Eastman and C Cowie
NIDDK/NIH, Bethesda, MD 20892.

OBJECTIVE--To ascertain the prevalence and determinants of sensory neuropathy symptoms through structured interview of a representative sample of people with diabetes in the U.S. population. RESEARCH DESIGN AND METHODS--The 1989 National Health Interview Survey consisted of a representative sample of 84,572 persons in the U.S. > or = 18 yr of age. A household respondent identified all people in the household believed to have diabetes (n = 2829). Subjects who could not be personally interviewed (n = 129) and individuals who stated they did not have diabetes (n = 295) were excluded. A detailed questionnaire was administered to 99.3% of the remaining 2405 subjects. Questions on symptoms of sensory neuropathy included whether during the past 3 mo the subjects had experienced numbness or loss of feeling, pain or tingling, or decreased ability to feel hot or cold. The neuropathy questions were also administered to a representative sample of 20,037 subjects who were not known to have diabetes. RESULTS--Prevalence of symptoms of sensory neuropathy was 30.2% among people with IDDM. This prevalence was 36.0% for men with NIDDM and 39.8% for women with NIDDM, compared with 9.8 and 11.8% for nondiabetic men and women, respectively. In logistic regression, factors independently related to symptoms of sensory neuropathy in people with NIDDM included duration of diabetes, hypertension, hyperglycemia, and glycosuria. Long duration of NIDDM (> or = 20 yr) was associated with a twofold increased risk of symptoms of sensory neuropathy compared with those with 0-4 yr of diabetes. Hypertension was associated with a 60% higher likelihood of symptoms. Diabetic individuals whose blood glucose was high all or most of the time or whose urine tests showed glucose all of the time were > 2 times as likely to have symptoms of sensory neuropathy than those who did not report hyperglycemia or glycosuria. Age, sex, ethnicity, cigarette smoking, and height were not determinants of sensory neuropathy. CONCLUSIONS--Symptoms of sensory neuropathy affect 30-40% of diabetic patients in the U.S. Men and women are affected equally. Prevalence of these symptoms increases with longer duration of diabetes; hypertension and hyperglycemia predispose to symptoms of sensory neuropathy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Mier, A. Bocanegra-Alonso, D. Zhan, S. Wang, S. M. Stoltz, R. I. Acosta-Gonzalez, and M. A. Zuniga Clinical Depressive Symptoms and Diabetes in a Binational Border Population J Am Board Fam Med, May 1, 2008; 21(3): 223 - 233. [Abstract] [Full Text] [PDF]

				B. Perrin and H. Swerissen The Behavior and Psychological Functioning of People at High Risk of Diabetes-Related Foot Complications The Diabetes Educator, May 1, 2008; 34(3): 493 - 500. [Abstract] [Full Text] [PDF]

				D. Ziegler, W. Rathmann, T. Dickhaus, C. Meisinger, A. Mielck, and for the KORA Study Group Prevalence of Polyneuropathy in Pre-Diabetes and Diabetes Is Associated With Abdominal Obesity and Macroangiopathy: The MONICA/KORA Augsburg Surveys S2 and S3 Diabetes Care, March 1, 2008; 31(3): 464 - 469. [Abstract] [Full Text] [PDF]

				S. Tesfaye, R. Tandan, E. J. Bastyr III, K. A. Kles, V. Skljarevski, K. L. Price, and for the Ruboxistaurin Study Group Factors That Impact Symptomatic Diabetic Peripheral Neuropathy in Placebo-Administered Patients From Two 1-Year Clinical Trials Diabetes Care, October 1, 2007; 30(10): 2626 - 2632. [Abstract] [Full Text] [PDF]

				Y. J. Cheng, E. W. Gregg, H. S. Kahn, D. E. Williams, N. De Rekeneire, and K. M. V. Narayan Peripheral Insensate Neuropathy--A Tall Problem for US Adults? Am. J. Epidemiol., November 1, 2006; 164(9): 873 - 880. [Abstract] [Full Text] [PDF]

				A. D. Westanmo, J. Gayken, and R. Haight Duloxetine: A balanced and selective norepinephrine- and serotonin-reuptake inhibitor Am. J. Health Syst. Pharm., December 1, 2005; 62(23): 2481 - 2490. [Abstract] [Full Text] [PDF]

				H. M. Rathur and A. J. M. Boulton Recent advances in the diagnosis and management of diabetic neuropathy J Bone Joint Surg Br, December 1, 2005; 87-B(12): 1605 - 1610. [Full Text] [PDF]

				S. Tesfaye, N. Chaturvedi, S. E.M. Eaton, J. D. Ward, C. Manes, C. Ionescu-Tirgoviste, D. R. Witte, J. H. Fuller, and the EURODIAB Prospective Complications Study Group Vascular Risk Factors and Diabetic Neuropathy N. Engl. J. Med., January 27, 2005; 352(4): 341 - 350. [Abstract] [Full Text] [PDF]

				B. E. K. Klein, R. Klein, P. E. McBride, K. J. Cruickshanks, M. Palta, M. D. Knudtson, S. E. Moss, and J. O. Reinke Cardiovascular Disease, Mortality, and Retinal Microvascular Characteristics in Type 1 Diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy Arch Intern Med, September 27, 2004; 164(17): 1917 - 1924. [Abstract] [Full Text] [PDF]

				E. W. Gregg, P. Sorlie, R. Paulose-Ram, Q. Gu, M. S. Eberhardt, M. Wolz, V. Burt, L. Curtin, M. Engelgau, and L. Geiss Prevalence of Lower-Extremity Disease in the U.S. Adult Population >=40 Years of Age With and Without Diabetes: 1999-2000 National Health and Nutrition Examination Survey Diabetes Care, July 1, 2004; 27(7): 1591 - 1597. [Abstract] [Full Text] [PDF]

				A. J.M. Boulton, R. A. Malik, J. C. Arezzo, and J. M. Sosenko Diabetic Somatic Neuropathies Diabetes Care, June 1, 2004; 27(6): 1458 - 1486. [Full Text] [PDF]

				L L Teunissen, H Franssen, J H J Wokke, Y van der Graaf, W H J P Linssen, J D Banga, D M Laman, and N C Notermans Is cardiovascular disease a risk factor in the development of axonal polyneuropathy? J. Neurol. Neurosurg. Psychiatry, May 1, 2002; 72(5): 590 - 595. [Abstract] [Full Text] [PDF]

				T. Kastenbauer, S. Sauseng, G. Sokol, M. Auinger, and K. Irsigler A Prospective Study of Predictors for Foot Ulceration in Type 2 Diabetes J Am Podiatr Med Assoc, July 1, 2001; 91(7): 343 - 350. [Abstract] [Full Text] [PDF]

				H. E. Resnick, A. I. Vinik, H. K. Heimovitz, F. L. Brancati, and J. M. Guralnik Age 85+ Years Accelerates Large-Fiber Peripheral Nerve Dysfunction and Diabetes Contributes Even in the Oldest-Old: The Women's Health and Aging Study J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 25M - 31. [Abstract] [Full Text]

				I. M Stratton, A. I Adler, H A. W Neil, D. R Matthews, S. E Manley, C. A Cull, D. Hadden, R. C Turner, and R. R Holman Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ, August 12, 2000; 321(7258): 405 - 412. [Abstract] [Full Text]

				D. L Somers and M. F Somers Treatment of Neuropathic Pain in a Patient With Diabetic Neuropathy Using Transcutaneous Electrical Nerve Stimulation Applied to the Skin of the Lumbar Region Physical Therapy, August 1, 1999; 79(8): 767 - 775. [Abstract] [Full Text] [PDF]